{"ticker": {"uuid": "0c30525e-bb29-4e07-ada3-96c6e14349f7", "symbol": "VCEL", "name": "Vericel Corp Ord", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Vericel (VCEL) COO exercises options, sells 10,000 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNanpRb1FhbmdQUldVUFphUm0xZVFxeVJ6WElRVTRZVTFHR095U2JmUTBvckZEcE0xZm1pTnNrNlh2YWlpTndrNUU0R2I2QWpMSjdvMk9ZQXdxY1ZvSEg0cnBNdmZ4VnZqNHBPQlRqQXdncXI4N1lfUzJUeDBWOEluZlNNR3RaRXFCRmJIeUplQVgzZDhKYXh0TDRoSWYxU0tPWkF2QV9XaWUyQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T20:05:51+00:00", "published_display": "22 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (NASDAQ: VCEL) CLO exercises options and sells 15K shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQVl9YLURzWjliTEIyU1dVQXdqaGxocVFpZjZhaFFBdDktSnlCNTBVOTZGYThIaTRSMmlscERJQ3BubklLU2tuYThWUFBIQ1NGTm5hQlh4dTNNdF96Z2lqcHRMYUFHVTdrRDZiVGxKRE8xc3V4amdsaThnMUlTazVtYzVKbE15M0I3T0lDTUZ6TUhwNVdBWXhsSWtKclZDVWNmQWpHM0pwaWdrZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T20:05:31+00:00", "published_display": "22 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) Stock Could Be 37.3% Undervalued After Earnings Beat And Fund Buying", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T01:33:55+00:00", "published_display": "22 Jun 2026 01:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) Is Up 7.0% After Earnings Beat And Conference Spotlight Has The Bull Case Changed?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQV2ljNVpfMFZhYW1IQjUxakl2RFg5ZElHemE3bmYtUHptTm8zdUtrQUdoclR0VFNaSk4xVm5MakZsWlJRVF96M1NTeFppVmFrNHE4RlBvSUJzWkFzREtGSzlrc2lsUk0tRUgwNjdoNU1aN0NNaDNnbHRUa0t2bVVLXzdSTUxwY2w5WGxwSVYtdDJSV0psWlJ5NkgtR0R4M0ZlelppUm5ESHFaTFNpT3hvT1B5dXJmUnpEQ0s2WjBPRi1hOFEtU2c0NkNzYlNrTVhoMjI1LTJ2VnViN252?oc=5", "source_name": "Sahm", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Vericel Corp SEC Filing", "summary": "This article reports a Form 144 SEC filing by Vericel Corp (VCEL) on June 18, 2026, indicating a proposed sale of 15,000 shares of common stock acquired through a stock option exercise, valued at $603,148.23. The filing details the transaction and confirms no prior sales within t", "url": "https://www.stocktitan.net/sec-filings/VCEL/144-vericel-corp-sec-filing-ba6f786af8b7.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:40:29", "published_display": "18 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Vericel Corp (VCEL) by business segment and region. As of FY2024, the company's revenue heavily relies on its MACI product (86.70%), followed by Epicel (11.61%) and NexoBrid (1.70%). All reported revenue originates from the U", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T09:40:30", "published_display": "18 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Vericel Corp (VCEL), outlining both major individual shareholders and the types of institutional investors holding its stock. It provides a breakdown of proportional holdings by firms like BlackRock, State Street, and Vanguard, al", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:30", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Vericel Corp (VCEL)'s dividend and stock split history. It notes that the company has not distributed any dividends over the past five years and has no recorded stock splits. The page also displays current stock information such as market cap ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T00:39:30", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Vericel Corp (VCEL) has an earnings forecast score of 8.50, ranking 34th in the Pharmaceuticals industry. Analysts have an average price target of $55.00 for VCEL, with the majority recommending a \"Buy\" trend. The company's expected revenue for the next quarter is $72.69 million,", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T01:10:19", "published_display": "17 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Institutional Confidence", "summary": "Vericel Corp (VCEL) has a high institutional shareholding score of 10.00, placing it first in the Pharmaceuticals industry. Institutional shareholding has increased by 11.74% quarter-over-quarter, with BlackRock and State Street being among the top institutional holders. Steven C", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T01:10:19", "published_display": "17 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (NASDAQ:VCEL): Growth and Technical Setup Align for Potential Breakout", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQdTRFVkpFb1I2VDY2Y1JWTThCTWM1YllPbDQ5YnlPdUh2dmY5Y2IxZFBPcVpCRk1Bc0pEancxeXdyMkNieDBSYnJoeVhQSFZDeHE2RXhDeS10NFV2a1dMenUtajUyMFphcWVpandBYVlGdzBDTmwyOHZ4VEZnbFRfYlQ5VmRwWS1oMWxjWVdpX3FXNGxUYlJRLWlscHNDM2YyeEJacTEzOE11bHdzekRuQ2RxUVdLZFFteGRyRTZGdERLV1ZJb1luUDhocw?oc=5", "source_name": "ChartMill", "published_at": "2026-06-16T08:10:43+00:00", "published_display": "16 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Vericel (VCEL)", "summary": "This article provides an overview of analyst ratings for two healthcare companies, Rezolute (RZLT) and Vericel (VCEL). Douglas Tsao from H.C. Wainwright reiterated a Buy rating for Rezolute with a $5.00 price target, while Josh Jennings from TD Cowen reiterated a Buy rating for V", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2413956/analysts-offer-insights-on-healthcare-companies-rezolute-rzlt-and-vericel-vcel/", "source_name": "The Globe and Mail", "published_at": "2026-06-11T11:09:13", "published_display": "11 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How to watch Vericel's June 16 Truist MedTech talk online", "summary": "Vericel (NASDAQ: VCEL) announced it will present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026. A live webcast of the presentation will be accessible through the Investor Relations section of Vericel's website. The company's stock saw a 4.14% gain on ", "url": "https://www.stocktitan.net/news/VCEL/vericel-to-present-at-the-2026-truist-securities-med-tech-conference-6ky9ku2qblzn.html", "source_name": "Stock Titan", "published_at": "2026-06-09T23:39:44", "published_display": "09 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026", "summary": "Vericel Corporation announced it will present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026. A webcast of the presentation will be available on the Investor Relations section of the Company's website. Vericel is a leader in advanced therapies for spor", "url": "https://finance.yahoo.com/sectors/healthcare/articles/vericel-present-2026-truist-securities-123000571.html", "source_name": "Market source", "published_at": "2026-06-09T12:08:49", "published_display": "09 Jun 2026 12:08", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) CMO sells 4,375 shares after option exercise", "summary": "Vericel Corp's Chief Medical Officer, Jonathan Mark Hopper, exercised stock options for 4,375 shares at $16.66 per share and simultaneously sold those 4,375 shares at $35.00 per share. These transactions were executed automatically under a pre-arranged Rule 10b5-1 trading plan. A", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-2f707a26970d.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:09:30", "published_display": "04 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Proposed sale of 4,375 VCEL shares (NASDAQ: VCEL)", "summary": "A recently filed Form 144 by Vericel Corp (VCEL) indicates a proposed sale of 4,375 shares of common stock by Fidelity Brokerage Services LLC, dated June 2, 2026, described as an \"option-related sale with cash proceeds.\" The filing also notes a past sale by Jonathan M. Hopper of ", "url": "https://www.stocktitan.net/sec-filings/VCEL/144-vericel-corp-sec-filing-78cf161edc09.html", "source_name": "Stock Titan", "published_at": "2026-06-02T18:51:28", "published_display": "02 Jun 2026 18:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More", "summary": "Soleus Capital Management recently bought an additional 1.785 million shares of Vericel (NASDAQ:VCEL), an estimated $63.40 million investment. Despite recent struggles in its stock price, Vericel's revenue climbed 20% year over year, with gross margins expanding and adjusted EBIT", "url": "https://finance.yahoo.com/sectors/healthcare/articles/vericel-revenue-jumped-20-one-185934175.html", "source_name": "Market source", "published_at": "2026-05-30T18:59:00", "published_display": "30 May 2026 18:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) amends bylaws to reflect new Burlington, MA global headquarters", "summary": "Vericel Corporation (VCEL) has amended its corporate bylaws to reflect its new global headquarters located at 25 Blue Sky Drive, Burlington, Massachusetts 01803. The amendment was approved by the Board of Directors and became effective on May 18, 2026. This change ensures that th", "url": "https://www.stocktitan.net/sec-filings/VCEL/8-k-vericel-corp-reports-material-event-b2c2b95bcf86.html", "source_name": "Stock Titan", "published_at": "2026-05-19T20:10:40", "published_display": "19 May 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corporation $VCEL Stock Position Reduced by Truist Financial Corp", "summary": "Truist Financial Corp reduced its stake in Vericel Corporation ($VCEL) by 59.9% in the fourth quarter, selling 37,035 shares and retaining 24,763 shares valued at approximately $892,000. Despite this reduction, other institutional investors increased their positions, and Vericel'", "url": "https://www.marketbeat.com/instant-alerts/filing-vericel-corporation-vcel-stock-position-reduced-by-truist-financial-corp-2026-05-18/", "source_name": "MarketBeat", "published_at": "2026-05-18T11:09:25", "published_display": "18 May 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) director McLaughlin exercises options and sells 7,000 shares", "summary": "Vericel Corp director Kevin F. McLaughlin exercised stock options to acquire 7,000 shares and subsequently sold all 7,000 shares in open-market transactions on May 13, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025. After these", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-f656b4641440.html", "source_name": "Stock Titan", "published_at": "2026-05-15T20:13:34", "published_display": "15 May 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Vericel director Paul Wotton sells $327,425 in company stock By Investing.com", "summary": "Paul K. Wotton, a director at Vericel Corp, sold 10,000 shares of the company's common stock for a total of $327,425 on May 11, 2026. The stock traded between $32.64 and $33.05 per share, and following the sale, Wotton directly holds 18,802 shares. Despite a recent decline of ove", "url": "https://ng.investing.com/news/insider-trading-news/vericel-director-paul-wotton-sells-327425-in-company-stock-93CH-2507308", "source_name": "Investing.com Nigeria", "published_at": "2026-05-14T11:10:31", "published_display": "14 May 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Vericel director Paul Wotton sells $327,425 in company stock", "summary": "Vericel director Paul Wotton sold 10,000 shares of Vericel Corp (NASDAQ:VCEL) common stock for $327,425 on May 11, 2026, with the shares trading between $32.64 and $33.05. Despite this sale and a recent stock decline, InvestingPro suggests the company is undervalued. Vericel also", "url": "https://www.investing.com/news/insider-trading-news/vericel-director-paul-wotton-sells-327425-in-company-stock-93CH-4686176", "source_name": "Investing.com", "published_at": "2026-05-13T20:39:03", "published_display": "13 May 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Paul K. Wotton sells 10,000 Vericel (VCEL) shares around $33", "summary": "Vericel director Paul K. Wotton sold a total of 10,000 shares of common stock in open-market transactions on May 11, 2026. The sales were executed in two separate transactions at prices of $32.64 and $33.05 per share, amounting to a net sale of $327,425. Following these transacti", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-9dcc87a446de.html", "source_name": "Stock Titan", "published_at": "2026-05-13T20:09:59", "published_display": "13 May 2026 20:09", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Issuer (NASDAQ: VCEL) notifies sale of 7,000 common shares", "summary": "Vericel Corporation (NASDAQ: VCEL) has filed a Form 144 notice to sell 7,000 shares of common stock through Fidelity Brokerage Services LLC on May 13, 2026. These shares originate from two option grants issued in 2017 and 2018, each for 3,500 shares. The filing is a regulatory in", "url": "https://www.stocktitan.net/sec-filings/VCEL/144-vericel-corp-sec-filing-6c9e4a744b6f.html", "source_name": "Stock Titan", "published_at": "2026-05-13T18:09:59", "published_display": "13 May 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Vericel Corporation (NASDAQ:VCEL) Q1 2026 Earnings Call Transcript", "summary": "Vericel Corporation (NASDAQ:VCEL) reported a strong Q1 2026, with total revenue exceeding $68 million, a 30% increase year-over-year, driven by substantial growth in both MACI and the Burn Care business. The company raised its full-year 2026 revenue guidance by $10 million to a r", "url": "https://www.insidermonkey.com/blog/vericel-corporation-nasdaqvcel-q1-2026-earnings-call-transcript-1757913/", "source_name": "Insider Monkey", "published_at": "2026-05-09T12:39:15", "published_display": "09 May 2026 12:39", "sentiment": "positive", "sentiment_pct": 86, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPaWFLX25vOFQwM3JLZnJpZEZMaVVVemZhMWxCY3NxN2QxeDlYSENXbmwyUEktS2pOT3NOTWc0WjNSSHh6VkxlX2Z3d1MwUTM5Ul9hN1IxeURyTExSVk93SkE0c1ZkbXNhZG1lZ2xnbmRsWnI4YUR5VnY3VlJraGJBVWtURzN3dk9vOHlteXlTdjlnaDMzQm02UVY1Vm5yMEs0RHV1ZzZyRFNobTN4NFljMlNR?oc=5", "source_name": "ChartMill", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Made A Financial Statement On Vericel Corporation's (NASDAQ:VCEL) First-Quarter Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcUhRTG1YVFcyeWh3a0J1Z0JjdWRKZXYwQUtuMHJrUDZCSm5aQnJqVGo4dFlhQm5SUzZRWXNTc1Y5QW5RZVpzdllNVEhJYXVnMEx4bXdsZEtNUmstalo2cllQTGtzTG1yTHc3SHo5dFVNdkxHZFFXbENpdXlZeDlNZDU1WmtadVNIQXFaNnpTNEE0RVZiejgzM0RvSjZFLTFJX1ZKRTd0Y2JPUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/62578dbd-70f1-33e4-ba8c-86428f790bae/vericel-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-09T06:07:54+00:00", "published_display": "09 May 2026 06:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Mara Joseph Anthony Jr Sells 5,000 Shares of Veric", "summary": "Mara Joseph Anthony Jr, CFO of Vericel Corp (VCEL), recently sold 5,000 shares, reducing his holdings to 21,009 shares. Over the past year, there have been 17 insider sells and no insider buys at Vericel. The stock, trading at $40.50, is considered significantly undervalued again", "url": "https://www.gurufocus.com/news/8846964/insider-sell-mara-joseph-anthony-jr-sells-5000-shares-of-vericel-corp-vcel?mobile=true", "source_name": "GuruFocus", "published_at": "2026-05-09T00:10:29", "published_display": "09 May 2026 00:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (NASDAQ: VCEL) accounting chief sells 4,855 shares", "summary": "Vericel's Principal Accounting Officer, Jonathan Siegal, sold a total of 4,855 shares of company common stock in open-market transactions on May 6 and May 7, 2026. These sales, valued at $188,045, were pre-arranged under a Rule 10b5-1 trading plan adopted in December 2025. Follow", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-495fc507d2af.html", "source_name": "Stock Titan", "published_at": "2026-05-08T20:10:29", "published_display": "08 May 2026 20:10", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) CFO 10b5-1 sale leaves 21,009 shares held", "summary": "Vericel Corp's CFO, Mara Joseph Anthony Jr, completed an automatic open-market sale of 5,000 shares of common stock at $40.50 per share on May 7, 2026. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025. Following the sale, the", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-19b7d40bca7a.html", "source_name": "Stock Titan", "published_at": "2026-05-08T20:10:28", "published_display": "08 May 2026 20:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/c9b8029e-64c0-3568-ac19-5bae4394d9f6/vericel-%28vcel%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T16:31:58+00:00", "published_display": "08 May 2026 16:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp 1Q 2026: Revenue $68.43M, EPS ($0.12) \u2014 10-Q Summary", "summary": "Vericel Corp (VCEL) reported its first-quarter 2026 results, showing revenue of $68.43 million, a 30.1% increase year-over-year from $52.6 million. The company narrowed its net loss to $6.3 million, or diluted EPS of ($0.12), significantly improving from a net loss of $11.25 mill", "url": "https://www.tradingview.com/news/tradingview:b006e16a6565d:0-vericel-corp-1q-2026-revenue-68-43m-eps-0-12-10-q-summary/", "source_name": "TradingView", "published_at": "2026-05-07T20:39:15", "published_display": "07 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp reports results for the quarter ended March 31 - Earnings Summary", "summary": "Vericel Corp has released its earnings summary for the quarter that ended on March 31. The report contains the financial results for the specified period. This news was originally reported by Reuters and published on TradingView.", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N41K1SW:0-vericel-corp-reports-results-for-the-quarter-ended-march-31-earnings-summary/", "source_name": "TradingView", "published_at": "2026-05-07T20:39:15", "published_display": "07 May 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Shares Rise After Q1 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Lifted", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/vericel-shares-rise-q1-net-141526502.html", "source_name": "MT Newswires", "published_at": "2026-05-07T14:15:26+00:00", "published_display": "07 May 2026 14:15", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/vericel-reports-first-quarter-2026-114500345.html", "source_name": "GlobeNewswire", "published_at": "2026-05-07T11:45:00+00:00", "published_display": "07 May 2026 11:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BARDA burns contract backs NexoBrid growth at Vericel (VCEL)", "summary": "Vericel Corporation (VCEL) reported strong first-quarter 2026 results with revenue up 30% to $68.4 million, driven by growth in MACI and Epicel sales, while net loss narrowed to $6.3 million. The company reinforced its financial position with $210.6 million in cash and investment", "url": "https://www.stocktitan.net/sec-filings/VCEL/10-q-vericel-corp-quarterly-earnings-report-818c86ee9a17.html", "source_name": "Stock Titan", "published_at": "2026-05-07T12:39:47", "published_display": "07 May 2026 12:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Reports Q1 2026: Revenue Up 30% to $68.4M, Adjusted EBITDA $9.6M", "summary": "Vericel reported strong first-quarter 2026 results, with total net revenue increasing 30% to $68.4 million and adjusted EBITDA reaching $9.6 million. The company's gross margin was 72%, and it recorded a net loss of $6.3 million, alongside a healthy free cash flow of $15.1 millio", "url": "https://www.tradingview.com/news/tradingview:1c1f475c77115:0-vericel-reports-q1-2026-revenue-up-30-to-68-4m-adjusted-ebitda-9-6m/", "source_name": "TradingView", "published_at": "2026-05-07T12:09:14", "published_display": "07 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOS3FaODVEQ2QxckRjZmx3aG84RmxNbFpjR2d3c2plQWNiLWxwZ256NXFUWXhrNjg5ZWcyd2dqbXBNMTlFd1VkUGdLZUFXT1kwcy0yRDFSeWdkQjVRN1VobE4telhHa19hcmFmRF93UG5aN1ZBOXdEUlJ0NGZwb2JpTFdkTnJ5djRnbzM5aXNsMjA5Wm9MbXhVSXdzY0Flay1Vb0E?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNbDhiTndrc2lXcjE0bWNYVHB4em1CclM0dVNZWl9aNXJUMzEzY1BJNjVsQ0s0ZXZrMkRRRnNja0hRaWYwNDdRUS1IME1KNkNqbTRzNFBUVDl1TVdNOFJJV2pBLXlaX3NrZnJkdFNwSUx1eUJVbDFsUVA3czdRRDFfUkVNRWI1Y3JBaTRBbnFKb1lGb0ZlTFZaakxIVHpxZnVsdEhFODV5aE9fR0lQM3pLUWl3X3lMa1dWY2c1eXIyaVBHX28wZ05YTTBDQjZpSHdQOVE?oc=5", "source_name": "ChartMill", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNNnZIRV9Vd2k1ZklLMmc4RGowWXU2RVVvNk9HUWgtdThlaE11RnhuYXl1VzM1TWh1V1BpTk5EMGtZS3JicllOTlZiTUMzMWxlUDh5WGFCUUdidnFELUV6QmEzUjM4TXdfYWVyR2F1a0dqeW5qdW1QdHZvZExBSjFtTkY5dFRVU3NWYUYzTlU5Ni1qcHpmNUQtZE5JLURjLWhT?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Vericel Corp ($VCEL) CEO 2025 Pay Revealed | VCEL Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSmxwYzZLU2hESF93eTlqd29oTTVLNU85SG9BWER1MXVnZkxzRllfSlVDTTZTRWRWOHBXY2VKSVdQLWs1ekpITTU4WmhscjV3bnN1azZ0aGUzWGRaNUNTZ2ZNSDZnRUN2dTBYelBWNC1uT1BTT1JUWnA3djd2Sk12bEtUY2NnN1Vx?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Vericel Corporation (VCEL) an Investment Bet?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNTlVCdXMtNEJacUp1WUJRdWVJbkhTb3hzMzFSV2NsNGVjS3JZQ2ptWVBNNGVDSFhNOG5xOHlSTUQxVEdOVkZERXRUZUtSb19wRFhKS2Y5WUxqcTJNSUJVWHViZEdnWjg4bzRrd2ZSSFdwTkxBd3NTUWEyZ0dKZ0Y1dmV1V1VQalk2MktYVW0tRkM?oc=5", "source_name": "Market source", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA approves new Vericel cell therapy plant to expand cartilage repair", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQb21zQXF1TlR4WVZTOE10a2Jrc1NKZHdxZy1fenJIWXNjMkM1dWNMek9SWnJzZzV3LUpIRnF2RUVUR3AtbWttQ0k0WlY1dVlRX1gtS3c3cTZMNmFnWGxjSUZDQlpKUjhrcXNLUnMzYlVXdHNkVS1TbWVKRkY1ZEl1RVpMSnotaE5uX0IwN3JqMy1xbFB6UVZGZy1pdW5YTkdZUzVEMmpaQmFuOGFpeXdOb0diUmJWeVcxOXc?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There's No Escaping Vericel Corporation's (NASDAQ:VCEL) Muted Revenues Despite A 29% Share Price Rise", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-12T08:00:00+00:00", "published_display": "12 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Vericel (VCEL) COO exercises options, sells 10,000 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNanpRb1FhbmdQUldVUFphUm0xZVFxeVJ6WElRVTRZVTFHR095U2JmUTBvckZEcE0xZm1pTnNrNlh2YWlpTndrNUU0R2I2QWpMSjdvMk9ZQXdxY1ZvSEg0cnBNdmZ4VnZqNHBPQlRqQXdncXI4N1lfUzJUeDBWOEluZlNNR3RaRXFCRmJIeUplQVgzZDhKYXh0TDRoSWYxU0tPWkF2QV9XaWUyQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T20:05:51+00:00", "published_display": "22 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (NASDAQ: VCEL) CLO exercises options and sells 15K shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQVl9YLURzWjliTEIyU1dVQXdqaGxocVFpZjZhaFFBdDktSnlCNTBVOTZGYThIaTRSMmlscERJQ3BubklLU2tuYThWUFBIQ1NGTm5hQlh4dTNNdF96Z2lqcHRMYUFHVTdrRDZiVGxKRE8xc3V4amdsaThnMUlTazVtYzVKbE15M0I3T0lDTUZ6TUhwNVdBWXhsSWtKclZDVWNmQWpHM0pwaWdrZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T20:05:31+00:00", "published_display": "22 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) Stock Could Be 37.3% Undervalued After Earnings Beat And Fund Buying", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T01:33:55+00:00", "published_display": "22 Jun 2026 01:33", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) Is Up 7.0% After Earnings Beat And Conference Spotlight Has The Bull Case Changed?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQV2ljNVpfMFZhYW1IQjUxakl2RFg5ZElHemE3bmYtUHptTm8zdUtrQUdoclR0VFNaSk4xVm5MakZsWlJRVF96M1NTeFppVmFrNHE4RlBvSUJzWkFzREtGSzlrc2lsUk0tRUgwNjdoNU1aN0NNaDNnbHRUa0t2bVVLXzdSTUxwY2w5WGxwSVYtdDJSV0psWlJ5NkgtR0R4M0ZlelppUm5ESHFaTFNpT3hvT1B5dXJmUnpEQ0s2WjBPRi1hOFEtU2c0NkNzYlNrTVhoMjI1LTJ2VnViN252?oc=5", "source_name": "Sahm", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Vericel Corp SEC Filing", "summary": "This article reports a Form 144 SEC filing by Vericel Corp (VCEL) on June 18, 2026, indicating a proposed sale of 15,000 shares of common stock acquired through a stock option exercise, valued at $603,148.23. The filing details the transaction and confirms no prior sales within t", "url": "https://www.stocktitan.net/sec-filings/VCEL/144-vericel-corp-sec-filing-ba6f786af8b7.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:40:29", "published_display": "18 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Vericel Corp (VCEL) by business segment and region. As of FY2024, the company's revenue heavily relies on its MACI product (86.70%), followed by Epicel (11.61%) and NexoBrid (1.70%). All reported revenue originates from the U", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T09:40:30", "published_display": "18 Jun 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Vericel Corp (VCEL), outlining both major individual shareholders and the types of institutional investors holding its stock. It provides a breakdown of proportional holdings by firms like BlackRock, State Street, and Vanguard, al", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T01:39:30", "published_display": "18 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Vericel Corp (VCEL)'s dividend and stock split history. It notes that the company has not distributed any dividends over the past five years and has no recorded stock splits. The page also displays current stock information such as market cap ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T00:39:30", "published_display": "18 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Vericel Corp (VCEL) has an earnings forecast score of 8.50, ranking 34th in the Pharmaceuticals industry. Analysts have an average price target of $55.00 for VCEL, with the majority recommending a \"Buy\" trend. The company's expected revenue for the next quarter is $72.69 million,", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T01:10:19", "published_display": "17 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (VCEL) Institutional Confidence", "summary": "Vericel Corp (VCEL) has a high institutional shareholding score of 10.00, placing it first in the Pharmaceuticals industry. Institutional shareholding has increased by 11.74% quarter-over-quarter, with BlackRock and State Street being among the top institutional holders. Steven C", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-vcel/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T01:10:19", "published_display": "17 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (NASDAQ:VCEL): Growth and Technical Setup Align for Potential Breakout", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQdTRFVkpFb1I2VDY2Y1JWTThCTWM1YllPbDQ5YnlPdUh2dmY5Y2IxZFBPcVpCRk1Bc0pEancxeXdyMkNieDBSYnJoeVhQSFZDeHE2RXhDeS10NFV2a1dMenUtajUyMFphcWVpandBYVlGdzBDTmwyOHZ4VEZnbFRfYlQ5VmRwWS1oMWxjWVdpX3FXNGxUYlJRLWlscHNDM2YyeEJacTEzOE11bHdzekRuQ2RxUVdLZFFteGRyRTZGdERLV1ZJb1luUDhocw?oc=5", "source_name": "ChartMill", "published_at": "2026-06-16T08:10:43+00:00", "published_display": "16 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Vericel (VCEL)", "summary": "This article provides an overview of analyst ratings for two healthcare companies, Rezolute (RZLT) and Vericel (VCEL). Douglas Tsao from H.C. Wainwright reiterated a Buy rating for Rezolute with a $5.00 price target, while Josh Jennings from TD Cowen reiterated a Buy rating for V", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/2413956/analysts-offer-insights-on-healthcare-companies-rezolute-rzlt-and-vericel-vcel/", "source_name": "The Globe and Mail", "published_at": "2026-06-11T11:09:13", "published_display": "11 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How to watch Vericel's June 16 Truist MedTech talk online", "summary": "Vericel (NASDAQ: VCEL) announced it will present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026. A live webcast of the presentation will be accessible through the Investor Relations section of Vericel's website. The company's stock saw a 4.14% gain on ", "url": "https://www.stocktitan.net/news/VCEL/vericel-to-present-at-the-2026-truist-securities-med-tech-conference-6ky9ku2qblzn.html", "source_name": "Stock Titan", "published_at": "2026-06-09T23:39:44", "published_display": "09 Jun 2026 23:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026", "summary": "Vericel Corporation announced it will present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026. A webcast of the presentation will be available on the Investor Relations section of the Company's website. Vericel is a leader in advanced therapies for spor", "url": "https://finance.yahoo.com/sectors/healthcare/articles/vericel-present-2026-truist-securities-123000571.html", "source_name": "Market source", "published_at": "2026-06-09T12:08:49", "published_display": "09 Jun 2026 12:08", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) CMO sells 4,375 shares after option exercise", "summary": "Vericel Corp's Chief Medical Officer, Jonathan Mark Hopper, exercised stock options for 4,375 shares at $16.66 per share and simultaneously sold those 4,375 shares at $35.00 per share. These transactions were executed automatically under a pre-arranged Rule 10b5-1 trading plan. A", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-2f707a26970d.html", "source_name": "Stock Titan", "published_at": "2026-06-04T20:09:30", "published_display": "04 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Proposed sale of 4,375 VCEL shares (NASDAQ: VCEL)", "summary": "A recently filed Form 144 by Vericel Corp (VCEL) indicates a proposed sale of 4,375 shares of common stock by Fidelity Brokerage Services LLC, dated June 2, 2026, described as an \"option-related sale with cash proceeds.\" The filing also notes a past sale by Jonathan M. Hopper of ", "url": "https://www.stocktitan.net/sec-filings/VCEL/144-vericel-corp-sec-filing-78cf161edc09.html", "source_name": "Stock Titan", "published_at": "2026-06-02T18:51:28", "published_display": "02 Jun 2026 18:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More", "summary": "Soleus Capital Management recently bought an additional 1.785 million shares of Vericel (NASDAQ:VCEL), an estimated $63.40 million investment. Despite recent struggles in its stock price, Vericel's revenue climbed 20% year over year, with gross margins expanding and adjusted EBIT", "url": "https://finance.yahoo.com/sectors/healthcare/articles/vericel-revenue-jumped-20-one-185934175.html", "source_name": "Market source", "published_at": "2026-05-30T18:59:00", "published_display": "30 May 2026 18:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) amends bylaws to reflect new Burlington, MA global headquarters", "summary": "Vericel Corporation (VCEL) has amended its corporate bylaws to reflect its new global headquarters located at 25 Blue Sky Drive, Burlington, Massachusetts 01803. The amendment was approved by the Board of Directors and became effective on May 18, 2026. This change ensures that th", "url": "https://www.stocktitan.net/sec-filings/VCEL/8-k-vericel-corp-reports-material-event-b2c2b95bcf86.html", "source_name": "Stock Titan", "published_at": "2026-05-19T20:10:40", "published_display": "19 May 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corporation $VCEL Stock Position Reduced by Truist Financial Corp", "summary": "Truist Financial Corp reduced its stake in Vericel Corporation ($VCEL) by 59.9% in the fourth quarter, selling 37,035 shares and retaining 24,763 shares valued at approximately $892,000. Despite this reduction, other institutional investors increased their positions, and Vericel'", "url": "https://www.marketbeat.com/instant-alerts/filing-vericel-corporation-vcel-stock-position-reduced-by-truist-financial-corp-2026-05-18/", "source_name": "MarketBeat", "published_at": "2026-05-18T11:09:25", "published_display": "18 May 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) director McLaughlin exercises options and sells 7,000 shares", "summary": "Vericel Corp director Kevin F. McLaughlin exercised stock options to acquire 7,000 shares and subsequently sold all 7,000 shares in open-market transactions on May 13, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025. After these", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-f656b4641440.html", "source_name": "Stock Titan", "published_at": "2026-05-15T20:13:34", "published_display": "15 May 2026 20:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel director Paul Wotton sells $327,425 in company stock By Investing.com", "summary": "Paul K. Wotton, a director at Vericel Corp, sold 10,000 shares of the company's common stock for a total of $327,425 on May 11, 2026. The stock traded between $32.64 and $33.05 per share, and following the sale, Wotton directly holds 18,802 shares. Despite a recent decline of ove", "url": "https://ng.investing.com/news/insider-trading-news/vericel-director-paul-wotton-sells-327425-in-company-stock-93CH-2507308", "source_name": "Investing.com Nigeria", "published_at": "2026-05-14T11:10:31", "published_display": "14 May 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel director Paul Wotton sells $327,425 in company stock", "summary": "Vericel director Paul Wotton sold 10,000 shares of Vericel Corp (NASDAQ:VCEL) common stock for $327,425 on May 11, 2026, with the shares trading between $32.64 and $33.05. Despite this sale and a recent stock decline, InvestingPro suggests the company is undervalued. Vericel also", "url": "https://www.investing.com/news/insider-trading-news/vericel-director-paul-wotton-sells-327425-in-company-stock-93CH-4686176", "source_name": "Investing.com", "published_at": "2026-05-13T20:39:03", "published_display": "13 May 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Paul K. Wotton sells 10,000 Vericel (VCEL) shares around $33", "summary": "Vericel director Paul K. Wotton sold a total of 10,000 shares of common stock in open-market transactions on May 11, 2026. The sales were executed in two separate transactions at prices of $32.64 and $33.05 per share, amounting to a net sale of $327,425. Following these transacti", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-9dcc87a446de.html", "source_name": "Stock Titan", "published_at": "2026-05-13T20:09:59", "published_display": "13 May 2026 20:09", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Issuer (NASDAQ: VCEL) notifies sale of 7,000 common shares", "summary": "Vericel Corporation (NASDAQ: VCEL) has filed a Form 144 notice to sell 7,000 shares of common stock through Fidelity Brokerage Services LLC on May 13, 2026. These shares originate from two option grants issued in 2017 and 2018, each for 3,500 shares. The filing is a regulatory in", "url": "https://www.stocktitan.net/sec-filings/VCEL/144-vericel-corp-sec-filing-6c9e4a744b6f.html", "source_name": "Stock Titan", "published_at": "2026-05-13T18:09:59", "published_display": "13 May 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corporation (NASDAQ:VCEL) Q1 2026 Earnings Call Transcript", "summary": "Vericel Corporation (NASDAQ:VCEL) reported a strong Q1 2026, with total revenue exceeding $68 million, a 30% increase year-over-year, driven by substantial growth in both MACI and the Burn Care business. The company raised its full-year 2026 revenue guidance by $10 million to a r", "url": "https://www.insidermonkey.com/blog/vericel-corporation-nasdaqvcel-q1-2026-earnings-call-transcript-1757913/", "source_name": "Insider Monkey", "published_at": "2026-05-09T12:39:15", "published_display": "09 May 2026 12:39", "sentiment": "positive", "sentiment_pct": 86, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPaWFLX25vOFQwM3JLZnJpZEZMaVVVemZhMWxCY3NxN2QxeDlYSENXbmwyUEktS2pOT3NOTWc0WjNSSHh6VkxlX2Z3d1MwUTM5Ul9hN1IxeURyTExSVk93SkE0c1ZkbXNhZG1lZ2xnbmRsWnI4YUR5VnY3VlJraGJBVWtURzN3dk9vOHlteXlTdjlnaDMzQm02UVY1Vm5yMEs0RHV1ZzZyRFNobTN4NFljMlNR?oc=5", "source_name": "ChartMill", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Made A Financial Statement On Vericel Corporation's (NASDAQ:VCEL) First-Quarter Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOcUhRTG1YVFcyeWh3a0J1Z0JjdWRKZXYwQUtuMHJrUDZCSm5aQnJqVGo4dFlhQm5SUzZRWXNTc1Y5QW5RZVpzdllNVEhJYXVnMEx4bXdsZEtNUmstalo2cllQTGtzTG1yTHc3SHo5dFVNdkxHZFFXbENpdXlZeDlNZDU1WmtadVNIQXFaNnpTNEE0RVZiejgzM0RvSjZFLTFJX1ZKRTd0Y2JPUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/62578dbd-70f1-33e4-ba8c-86428f790bae/vericel-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-09T06:07:54+00:00", "published_display": "09 May 2026 06:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Mara Joseph Anthony Jr Sells 5,000 Shares of Veric", "summary": "Mara Joseph Anthony Jr, CFO of Vericel Corp (VCEL), recently sold 5,000 shares, reducing his holdings to 21,009 shares. Over the past year, there have been 17 insider sells and no insider buys at Vericel. The stock, trading at $40.50, is considered significantly undervalued again", "url": "https://www.gurufocus.com/news/8846964/insider-sell-mara-joseph-anthony-jr-sells-5000-shares-of-vericel-corp-vcel?mobile=true", "source_name": "GuruFocus", "published_at": "2026-05-09T00:10:29", "published_display": "09 May 2026 00:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (NASDAQ: VCEL) accounting chief sells 4,855 shares", "summary": "Vericel's Principal Accounting Officer, Jonathan Siegal, sold a total of 4,855 shares of company common stock in open-market transactions on May 6 and May 7, 2026. These sales, valued at $188,045, were pre-arranged under a Rule 10b5-1 trading plan adopted in December 2025. Follow", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-495fc507d2af.html", "source_name": "Stock Titan", "published_at": "2026-05-08T20:10:29", "published_display": "08 May 2026 20:10", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) CFO 10b5-1 sale leaves 21,009 shares held", "summary": "Vericel Corp's CFO, Mara Joseph Anthony Jr, completed an automatic open-market sale of 5,000 shares of common stock at $40.50 per share on May 7, 2026. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025. Following the sale, the", "url": "https://www.stocktitan.net/sec-filings/VCEL/form-4-vericel-corp-insider-trading-activity-19b7d40bca7a.html", "source_name": "Stock Titan", "published_at": "2026-05-08T20:10:28", "published_display": "08 May 2026 20:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel (VCEL) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/c9b8029e-64c0-3568-ac19-5bae4394d9f6/vericel-%28vcel%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-08T16:31:58+00:00", "published_display": "08 May 2026 16:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp 1Q 2026: Revenue $68.43M, EPS ($0.12) \u2014 10-Q Summary", "summary": "Vericel Corp (VCEL) reported its first-quarter 2026 results, showing revenue of $68.43 million, a 30.1% increase year-over-year from $52.6 million. The company narrowed its net loss to $6.3 million, or diluted EPS of ($0.12), significantly improving from a net loss of $11.25 mill", "url": "https://www.tradingview.com/news/tradingview:b006e16a6565d:0-vericel-corp-1q-2026-revenue-68-43m-eps-0-12-10-q-summary/", "source_name": "TradingView", "published_at": "2026-05-07T20:39:15", "published_display": "07 May 2026 20:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp reports results for the quarter ended March 31 - Earnings Summary", "summary": "Vericel Corp has released its earnings summary for the quarter that ended on March 31. The report contains the financial results for the specified period. This news was originally reported by Reuters and published on TradingView.", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_L8N41K1SW:0-vericel-corp-reports-results-for-the-quarter-ended-march-31-earnings-summary/", "source_name": "TradingView", "published_at": "2026-05-07T20:39:15", "published_display": "07 May 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Shares Rise After Q1 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Lifted", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/vericel-shares-rise-q1-net-141526502.html", "source_name": "MT Newswires", "published_at": "2026-05-07T14:15:26+00:00", "published_display": "07 May 2026 14:15", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/vericel-reports-first-quarter-2026-114500345.html", "source_name": "GlobeNewswire", "published_at": "2026-05-07T11:45:00+00:00", "published_display": "07 May 2026 11:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BARDA burns contract backs NexoBrid growth at Vericel (VCEL)", "summary": "Vericel Corporation (VCEL) reported strong first-quarter 2026 results with revenue up 30% to $68.4 million, driven by growth in MACI and Epicel sales, while net loss narrowed to $6.3 million. The company reinforced its financial position with $210.6 million in cash and investment", "url": "https://www.stocktitan.net/sec-filings/VCEL/10-q-vericel-corp-quarterly-earnings-report-818c86ee9a17.html", "source_name": "Stock Titan", "published_at": "2026-05-07T12:39:47", "published_display": "07 May 2026 12:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Reports Q1 2026: Revenue Up 30% to $68.4M, Adjusted EBITDA $9.6M", "summary": "Vericel reported strong first-quarter 2026 results, with total net revenue increasing 30% to $68.4 million and adjusted EBITDA reaching $9.6 million. The company's gross margin was 72%, and it recorded a net loss of $6.3 million, alongside a healthy free cash flow of $15.1 millio", "url": "https://www.tradingview.com/news/tradingview:1c1f475c77115:0-vericel-reports-q1-2026-revenue-up-30-to-68-4m-adjusted-ebitda-9-6m/", "source_name": "TradingView", "published_at": "2026-05-07T12:09:14", "published_display": "07 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOS3FaODVEQ2QxckRjZmx3aG84RmxNbFpjR2d3c2plQWNiLWxwZ256NXFUWXhrNjg5ZWcyd2dqbXBNMTlFd1VkUGdLZUFXT1kwcy0yRDFSeWdkQjVRN1VobE4telhHa19hcmFmRF93UG5aN1ZBOXdEUlJ0NGZwb2JpTFdkTnJ5djRnbzM5aXNsMjA5Wm9MbXhVSXdzY0Flay1Vb0E?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNbDhiTndrc2lXcjE0bWNYVHB4em1CclM0dVNZWl9aNXJUMzEzY1BJNjVsQ0s0ZXZrMkRRRnNja0hRaWYwNDdRUS1IME1KNkNqbTRzNFBUVDl1TVdNOFJJV2pBLXlaX3NrZnJkdFNwSUx1eUJVbDFsUVA3czdRRDFfUkVNRWI1Y3JBaTRBbnFKb1lGb0ZlTFZaakxIVHpxZnVsdEhFODV5aE9fR0lQM3pLUWl3X3lMa1dWY2c1eXIyaVBHX28wZ05YTTBDQjZpSHdQOVE?oc=5", "source_name": "ChartMill", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNNnZIRV9Vd2k1ZklLMmc4RGowWXU2RVVvNk9HUWgtdThlaE11RnhuYXl1VzM1TWh1V1BpTk5EMGtZS3JicllOTlZiTUMzMWxlUDh5WGFCUUdidnFELUV6QmEzUjM4TXdfYWVyR2F1a0dqeW5qdW1QdHZvZExBSjFtTkY5dFRVU3NWYUYzTlU5Ni1qcHpmNUQtZE5JLURjLWhT?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vericel Corp ($VCEL) CEO 2025 Pay Revealed | VCEL Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSmxwYzZLU2hESF93eTlqd29oTTVLNU85SG9BWER1MXVnZkxzRllfSlVDTTZTRWRWOHBXY2VKSVdQLWs1ekpITTU4WmhscjV3bnN1azZ0aGUzWGRaNUNTZ2ZNSDZnRUN2dTBYelBWNC1uT1BTT1JUWnA3djd2Sk12bEtUY2NnN1Vx?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Vericel Corporation (VCEL) an Investment Bet?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNTlVCdXMtNEJacUp1WUJRdWVJbkhTb3hzMzFSV2NsNGVjS3JZQ2ptWVBNNGVDSFhNOG5xOHlSTUQxVEdOVkZERXRUZUtSb19wRFhKS2Y5WUxqcTJNSUJVWHViZEdnWjg4bzRrd2ZSSFdwTkxBd3NTUWEyZ0dKZ0Y1dmV1V1VQalk2MktYVW0tRkM?oc=5", "source_name": "Market source", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA approves new Vericel cell therapy plant to expand cartilage repair", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQb21zQXF1TlR4WVZTOE10a2Jrc1NKZHdxZy1fenJIWXNjMkM1dWNMek9SWnJzZzV3LUpIRnF2RUVUR3AtbWttQ0k0WlY1dVlRX1gtS3c3cTZMNmFnWGxjSUZDQlpKUjhrcXNLUnMzYlVXdHNkVS1TbWVKRkY1ZEl1RVpMSnotaE5uX0IwN3JqMy1xbFB6UVZGZy1pdW5YTkdZUzVEMmpaQmFuOGFpeXdOb0diUmJWeVcxOXc?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There's No Escaping Vericel Corporation's (NASDAQ:VCEL) Muted Revenues Despite A 29% Share Price Rise", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNeW1OaFE3ZWF6ZnJsRFNsSUV3Qm9ZSzFmTmczYUNlV2VqT3MxNjhLWjFRVWdhWEU0WDk4VW5VcUV4MUgxc1A4NWQ1VnlsNlRXb0VmU3c4bE42cXFoMG1FQ0k3ankxQW5tTFA2MUZOMXQyR0JrSnF0SDZyQURaWmNldDllNGs1MDBkbmZvWGVhNkQtd050dTZPTUhOVDh4dWtmU0FDWllqeTBXTmtVMmZwdkZ1RUJMekQxWFRBTlNnODFGdXBRRU8wNlVtWHkyR0NTVEpZWG5FcUvSAd4BQVVfeXFMTzJENHFkclN4S2NIOThRemZ2UGV2ZXpwTzhfVk5RQXZhMXJZMHY0allpRDRVYS1qNWJCRElJbUFrZ3VKeWZLbHRkZDB2T1JralB5dVNKQVYtQkhLRFFyVGtTUzhJc0FNNlRrTHNvUFN2TzR2R2FUZllfLVZBTHZCYVhxOTFwanh6cC0wY016RjhnUWxlSnlpQzJiZEwyS05xc21tOEZfb29POWFobUxmMzNDR1Jmd3lyWTdycjVyMWx3WGNKSlZhUWpCWDJ1ZEpvbHZGaG1tMWZkcUpaWXB3?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-12T08:00:00+00:00", "published_display": "12 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 90, "total_relevant": 52, "sentiment_summary": {"positive": 15, "negative": 6, "neutral": 31, "score": 54, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 13.75, "count": 25}, {"event": "earnings", "label": "Earnings", "weight": 11.69, "count": 23}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 40.1, "latest_week": "2026-06-19", "one_week_move": 7.0, "four_week_move": 15.5, "twelve_week_move": 36.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.738512, "market_dynamics_buy_signal": false, "relative_strength": -7.796161, "fair_value_gap": -3.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 43.3665, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+7.0% over one week, +15.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 14}, {"label": "Market source", "count": 11}, {"label": "TradingKey", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "ChartMill", "count": 3}, {"label": "TradingView", "count": 3}, {"label": "MarketBeat", "count": 2}, {"label": "Sahm", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 7}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 25}, {"label": "Earnings", "count": 23}, {"label": "Capital return", "count": 1}, {"label": "Analyst action", "count": 1}, {"label": "Balance sheet", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+7.0% over one week, +15.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Vericel (VCEL) COO exercises options, sells 10,000 shares under 10b5-1 plan"}], "updated_at": "2026-06-22T22:42:45.891837+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}